Changes of lipid metabolism in patients with rheumatoid arthritis and concomitant arterial hypertension, abdominal obesity and diabetes mellitus type 2 depending on the gene polymorphism T-786C of endothelial nitric oxide synthase
Journal Title: Міжнародний ендокринологічний журнал - Year 2017, Vol 13, Issue 1
Abstract
We have investigated the violations of blood lipid parameters in patients with rheumatoid arthritis (RA) combined with arterial hypertension (AH), abdominal obesity (AO) and diabetes mellitus type 2 (DM 2) depending on the gene polymorphism T-786C of endothelial nitric oxide synthase (eNOS). Materials and methods. The stage of screening was completed by 60 patients with rheumatoid arthritis, AH, AO and DM 2 and 20 apparently healthy people. The eNOS gene polymorphism (rs2070744) was determined by polymerase chain reaction, and during the evaluation of the lipid profile we took into account the presence of comorbid conditions. Results. The study showed that RA course was associated with dyslipidemia: a cholesterol level above population norm was detected in 61.67 % of patients, low-density lipoprotein cholesterol — almost in every second person (45.0 %), triglycerides (TG) — in 80.0 % of individuals, high-density lipoprotein (HDL) cholesterol, on the contrary, was below normal in 2/3 of patients (65.0 %). Typing of dyslipidemia indicates the presence in almost half of patients (45.0 %) of mixed ІІb type by D. Fredrickson, in every third (35.0 %) — endogenous hyperlipidemia type IV (hypertriglyceridemia). Conclusions. Changes in lipid metabolism taking into account polymorphic variants of eNOS gene (rs2070744) are associated with higher levels of TG in carriers of the mutant С-allele — by 81.71 % (рТТ = 0.04) and 36.58 % (рТТ = 0.015), as well as with a greater number of individuals with cholesterol levels above the population norm, among carriers of СС-genotype — by 75.0 % (p = 0.005). But among carriers of wild T-allele, there are more persons with a low content of antiatherogenic HDL cholesterol — by 31.04 % (p = 0.018) and 30.44 % (p = 0.039), and patients with high levels of TG — by 51.72 % (p < 0.001) and 56.52 % (p < 0.001), respectively.
Authors and Affiliations
O. P. Bukach, O. I. Fediv, L. P. Sydorchuk
Keywords
Related Articles
- EP ID EP176207
- DOI 10.22141/2224-0721.13.1.2017.96762
- Views 91
- Downloads 0
Influence of Hyperhomocysteinemia Correction on Functional Liver Tests and Lipid Profile in Patients with onalcoholic Fatty Liver Disease in Combination with Type 2 Diabetes Mellitus
Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (DM) are the components of metabolic syndrome, the incidence of which is increasing in the world every year. The article presents the results of treat...
The State of Microbiota of the Large Intestine in Patients with Type 1 Diabetes Mellitus Depending on the Age and Duration of the Disease
Introduction. Intestinal dysbiosis against the background of type 1 diabetes mellitus (DM) results in the development and unfavourable clinical course of chronic diseases, in particular of ENT-organs. Objective of the st...
The Use of Sugar Substitutes and Sweeteners in Diet Therapy of Diabetes and Obesity
The article provides a description of the main sugar substitutes and sweeteners that do not have negative impact on glycaemic parameters and can be used by patients with with diabetes mellitus and obesity without the fea...
Estimation of Thyroid Gland and Pancreatic Functioning in Patients with Chronic Hepatitis B and C Combined with Autoimmune Thyroiditis and without it
Chronic viral hepatitis is one of the most urgent problems of the healthcare. Viral hepatitis is not restricted with liver damage; they are like systemic disease proceeding with obligate development of extrahepatic manif...
Genetic basis of endocrine pathology
The purpose of the review was analysis of literature data relating to the molecular genetic basis and diagnosis of endocrine pathology. We searched for published and unpublished researches using Pubmed as the search engi...